Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Kay, A; Moser, C; McKhann, A; Vargas, M; Porrachia, M; Gianella, S; Hoenigl, M.
Soluble suppression of tumorigenicity 2 levels are not predictive of non-AIDS events during antiretroviral therapy-mediated viral suppression.
AIDS. 2019; 33(8):1397-1399
Doi: 10.1097/QAD.0000000000002228
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Hönigl Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- : Before initiation of antiretroviral therapy (ART), levels of soluble suppression of tumorigenicity 2 (sST2) were not elevated in people living with HIV who later developed non-AIDS events (including myocardial infarction and stroke), compared with controls. However, higher sST2 levels measured pre-ART were a significant predictor of death while on ART. Future studies should explore the potential of sST2 to serve as a short-term predictor of non-AIDS events during viral suppression.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Aged -
- Anti-Retroviral Agents - therapeutic use
- Death -
- Female -
- HIV Infections - drug therapy
- Humans -
- Interleukin-1 Receptor-Like 1 Protein - blood
- Longitudinal Studies -
- Male -
- Middle Aged -
- Predictive Value of Tests -
- Survival Analysis -
- Sustained Virologic Response -
- Young Adult -